Asghar et al. [38] conducted a study on 100 female breast cancer patients in Pakistani (including triple-negative and non-triple-negative ones), linking the expression of IDO with median overall survival, proving that IDO plays a pivotal role in TNBCs. The gene discussed is IDO1; the disease is breast cancer.